BSV, FOGSI partner to increase awareness, access of colposcopy
June 3, 2024
ET Healthworld
Colposcopy enables healthcare providers to identify abnormal cervical cells early, often before they develop into cancer
Press Release
Featured News
Nexobrid: A revolutionary treatment for burns to treat patients in few hours
Feb 24, 2024
Bharat Serums and Vaccines (BSV), a biopharmaceutical company in India, has recently inked an exclusive distribution agreement with MediWound (NASDAQ: MDWD) to introduce NexoBrid, a groundbreaking treatment for severe…
NABICON 2024 focuses on novel treatments like NexoBrid for burn management
Feb 19, 2024
The National Academy of Burns organized the NABICON 2024 at Ranchi was held from February 15 to 17 to explore the recent advances in all aspects of burn prevention, burn wound management, burn reconstruction, rehabilitation and research….
BSV, FOGSI collaborate to increase breastfeeding, post-partum care awareness through RISHTA 2024 initiative
Feb 7, 2024
Mumbai: Bharat Serums and…
Re-Pharma Summit 2024: Revamping India’s pharma supply chains for resilience
Feb 2, 2024
The panel discussion, titled ‘From Manufacturing to Patient: Ensuring Seamless Pharma Supply Chains in India’, explored the complexities faced during the COVID-19 pandemic, the critical need for the availability of essential…
Budget 2024 reality pill: Amid cervical cancer vaccine buzz, no word on GST demand miffs health industry
Feb 1, 2024
Budget 2024: Dr Roderico H. Ofrin, WHO Representative to India, said that ASHA workers, Anganwadi workers, and helpers are at the forefront of health and care delivery at the grassroots level…
Featured News
BSV, FOGSI organise the Run for gender equality
Dec 13, 2023
Part of a 28-city run, the initiative is aimed at connecting the country by spreading awareness for specific medical conditions such as anaemia…
BSV launches adverse event reporting application
Sep 27, 2023
BSV AER is directly connected to BSV’s pharmacovigilance system, which allows healthcare professionals (HCPs), consumers and company personnel to report these electronically from their smartphones or tablets from any…
BSV breaks ground for ₹200 crore bio-pharmaceutical plant at Genome Valley
Sep 21, 2023
Biotech firm Bharat Serums and Vaccines (BSV) broke ground for a ₹200 crore bio-pharmaceutical manufacturing plant at Genome Valley in Hyderabad on Thursday…..
Bharat Serums and Vaccines holds groundbreaking ceremony for new plant in Telangana
Sep 21, 2023
BSV currently has a manufacturing facility in Ambernath, Maharashtra that caters to the domestic market and more than 80 export markets…
Bharat Serums to expand women’s health business in Southeast Asia, Africa
Aug 25, 2023
Bharat Serums and Vaccines will focus on South-East Asia and Africa as target markets for its women’s health and critical care products in the coming years…
BSV ropes in Bureau Veritas India Pvt Ltd as part of BSV ART Act Readiness Programme
Jul 26, 2023
The programme will assess the current state of these centres against six critical parameters: infrastructure; people and competency management; communication; patient and process selection…
ETHealthworld Fertility Conclave 2023: Understanding persisting fertility issues in India
Feb 21, 2023
In our efforts to normalise the fertility conversation and transform it into a holistic dialogue, ETHealthworld brought prolific players of…
ETHealthworld Fertility Conclave 2023 convening fertility experts to deliberate on challenges, advancements and future
Feb 20, 2023
ETHealthworld presents the third edition of the Fertility Conclave, key players of the fertility ecosystem including fertility experts, researchers, pharmaceutical…
Amp Energy India commissions open-access solar project for Bharat Serums and Vaccines
Feb 6, 2023
Amp Energy India announced this week it has commissioned a 5 MW solar power plant for Bharat Serum and Vaccines Ltd (BSV), one of India’s leading vaccine biopharmaceutical majors…
Featured News
Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women’s health segment
Dec 15, 2022
Bharat Serums and Vaccines Limited (BSV) on Thursday said that it has entered into a definitive…
Bharat Serums and Vaccines’ antibody Covid treatment in Phase 2 trials
Jan 7, 2022
Biopharmaceutical company Bharat Serums and Vaccines (BSV) has expanded its research and development facilities and capabilities, with its work on…
Advent International emerges sole bidder for Bharat Serums
Jun 22, 2022
Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family…
BSV forges industry-academia collaboration with National Chemical Laboratory
Jun 12, 2022
The collaboration focuses on evaluation of certain recombinant cell line technologies developed by NCL for biopharmaceutical products currently under development at BSV…
Bharat Serums and Vaccines acquires key women health brand Tidilan from Jagdale Industries
Apr 5, 2022
Tidilan is used for relaxing uterine muscles to prevent premature labour, among expecting mothers. It belongs to a class of medication…
TTK Healthcare to sell human pharma biz to Bharat Serums
Mar 22, 2022
Chennai-based TTK Healthcare is set to sell its human pharma division to Mumbai-based Bharat Serums and Vaccines (BSV) for Rs 805 crore…
Women’s Right to Good Health
Jun 12, 2022
For every mother who loses her life due to childbirth-related reasons, several more suffer from lack of access to healthcare. Effective continuum of care for mothers…
Insurance coverage can augment IVF, making it more accessible
Apr 3, 2022
The issue of insurance in the healthcare industry, notably in the IVF sector, was explored. Panellists spoke about how to navigate the cost for patients and bring…
Co-Creating Futuristic Manifesto for Fertility Care in India
Feb 25, 2022
Top thought leaders participating in the 2nd virtual edition of ETHealthworld Fertility Conclave Powered by Bharat Serums and Vaccines Ltd deliberate…
For media inquiries, please contact Ms. Disha Karkera at disha.karkera@bsvgroup.com
